Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Jan;19(1):107-20.
doi: 10.1038/cdd.2011.96. Epub 2011 Jul 15.

Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012

Affiliations
Review

Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012

L Galluzzi et al. Cell Death Differ. 2012 Jan.

Abstract

In 2009, the Nomenclature Committee on Cell Death (NCCD) proposed a set of recommendations for the definition of distinct cell death morphologies and for the appropriate use of cell death-related terminology, including 'apoptosis', 'necrosis' and 'mitotic catastrophe'. In view of the substantial progress in the biochemical and genetic exploration of cell death, time has come to switch from morphological to molecular definitions of cell death modalities. Here we propose a functional classification of cell death subroutines that applies to both in vitro and in vivo settings and includes extrinsic apoptosis, caspase-dependent or -independent intrinsic apoptosis, regulated necrosis, autophagic cell death and mitotic catastrophe. Moreover, we discuss the utility of expressions indicating additional cell death modalities. On the basis of the new, revised NCCD classification, cell death subroutines are defined by a series of precise, measurable biochemical features.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Extrinsic apoptosis. Upon FAS ligand (FASL) binding, the cytoplasmic tails of FAS (also known as CD95, a prototypic death receptor) trimers recruit (among other proteins) FAS-associated protein with a death domain (FADD), cellular inhibitor of apoptosis proteins (cIAPs), c-FLIPs and pro-caspase-8 (or -10). This supramolecular platform, which has been dubbed ‘death-inducing signaling complex' (DISC), controls the activation of caspase-8 (-10). Within the DISC, c-FLIPs and cIAPs exert pro-survival functions. However, when lethal signals prevail, caspase-8 gets activated and can directly trigger the caspase cascade by mediating the proteolytic maturation of caspase-3 (in type I cells) or stimulate mitochondrial outer membrane permeabilization (MOMP) by cleaving the BH3-only protein BID (in type II cells). Extrinsic apoptosis can also be ignited by dependence receptors like DCC or UNC5B, which relay lethal signals in the absence of their ligand (netrin-1). In the case of DCC and UNC5B, the pro-apoptotic signaling proceeds through the assembly of a DRAL- and TUCAN- (or NLRP1-) containing caspase-9-activating platform or by the dephosphorylation-mediated activation of death-associated protein kinase 1 (DAPK1) by UNC5B-bound protein phosphatase 2A (PP2A), respectively. DAPK1 can mediate the direct activation of executioner caspases or favor MOMP. tBID, truncated BID
Figure 2
Figure 2
Intrinsic apoptosis. In response to multiple intracellular stress conditions (e.g., DNA damage, cytosolic Ca2+ overload), pro-survival and pro-death signals are generated and converge to a mitochondrion-centered control mechanism. When lethal signals prevail, mitochondrial outer membrane permeabilization (MOMP) occurs and leads to mitochondrial transmembrane potential (Δψm) dissipation, arrest of mitochondrial ATP synthesis and Δψm-dependent transport activities. Moreover, the respiratory chains gets uncoupled, leading to reactive oxygen species (ROS) overgeneration, and proteins that are normally confined within the mitochondrial intermembrane space (IMS) are released into the cytosol. Among these, cytochrome c (CYTC) drives – together with the cytoplasmic adaptor protein APAF1 and dATP – the assembly of the so-called apoptosome, a multiprotein complex that triggers the caspase-9 → caspase-3 proteolytic cascade. Direct IAP-binding protein with low pI (DIABLO, also known as second mitochondria-derived activator of caspases, SMAC) and high temperature requirement protein A2 (HTRA2) facilitate caspase activation by sequestering and/or degrading several members of the inhibitor of apoptosis protein (IAP) family. On the contrary, apoptosis-inducing factor (AIF) and endonuclease G (ENDOG) function in a caspase-independent manner by relocating to the nucleus and mediating large-scale DNA fragmentation. Of note, the serine protease HTRA2 also contributes to caspase-independent apoptosis by cleaving a wide array of cellular substrates (including cytoskeletal proteins). IM, mitochondrial inner membrane; OM, mitochondrial outer membrane; PTPC, permeability transition pore complex
Figure 3
Figure 3
Regulated necrosis. Upon tumor necrosis factor α (TNFα) binding, the cytoplasmic tails of TNF receptor 1 (TNFR1, a prototypic death receptor) trimers recruit TNFR-associated death domain (TRADD), receptor-interacting protein kinase 1 (RIP1), cellular inhibitor of apoptosis 1 (cIAP1), cIAP2, TNFR-associated factor 2 (TRAF2) and TRAF5. Within the so-called complex I, RIP1 is polyubiquitinated by cIAPs, thereby providing a docking site for the recruitment of transforming growth factor β (TGFβ)-activated kinase 1 (TAK1), TAK1-binding protein 2 (TAB2) and TAB3 (which together deliver a pro-survival signal by activating the transcription factor NF-κB). In some pathophysiological and experimental settings, and in particular when caspase-8 is absent or when caspases are inhibited by pharmacological agents, cylindromatosis (CYLD)-deubiquitinated RIP1 engage in physical and functional interactions with its homolog RIP3, ultimately activating the execution of necrotic cell death. Regulated necrosis can also be induced by alkylating DNA damage (possibly by the overactivation of poly(ADP-ribose) polymerase 1, PARP1). In some (but not all) instances, regulated necrosis requires the kinase activity of RIP1, that is, it can be blocked by the RIP1-targeting compounds necrostatins. FADD, FAS-associated protein with a death domain
Figure 4
Figure 4
Autophagic cell death. In response to stress and during development, eukaryotic cells often activate autophagy, a mechanism whereby organelles and portion of the cytoplasm are sequestered in double-membraned vesicles (autophagosomes) that are delivered to lysosomes for degradation. Stress-induced autophagy most often exerts cytoprotective functions and favors the re-establishment of homeostasis and survival (a). In this setting, pharmacological or genetic inhibition of autophagy accelerates cell death. On the contrary, these interventions frequently inhibit developmental cell death, indicating that autophagy also constitutes a lethal mechanism that mediates ‘autophagic cell death' (b)
Figure 5
Figure 5
Mitotic catastrophe. (a) In the absence of chemical and genetic perturbations of the mitotic apparatus (including chromosomes and the molecular machinery that ensures their faithful segregation), cells progress through the different phases of the cell cycle to generate a diploid offspring. On the contrary, if chromosomal defects or problems affecting the mitotic machinery are sensed during the M phase, cells become arrested in mitosis due to the activation of mitotic catastrophe (b–d). These cells can undergo different fates: they can die without exiting mitosis (b), reach the G1 phase of the subsequent cell cycle (through a phenomenon that is known as mitotic slippage) and then die (c), or exit mitosis and undergo senescence (d). Irrespective of this diversity of outcomes, mitotic catastrophe can be defined as an oncosuppressive mechanism that precedes and is distinct from, but operates through, cell death and senescence

Similar articles

  • Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009.
    Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, Hengartner M, Knight RA, Kumar S, Lipton SA, Malorni W, Nuñez G, Peter ME, Tschopp J, Yuan J, Piacentini M, Zhivotovsky B, Melino G; Nomenclature Committee on Cell Death 2009. Kroemer G, et al. Cell Death Differ. 2009 Jan;16(1):3-11. doi: 10.1038/cdd.2008.150. Epub 2008 Oct 10. Cell Death Differ. 2009. PMID: 18846107 Free PMC article.
  • Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.
    Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Annicchiarico-Petruzzelli M, Antonov AV, Arama E, Baehrecke EH, Barlev NA, Bazan NG, Bernassola F, Bertrand MJM, Bianchi K, Blagosklonny MV, Blomgren K, Borner C, Boya P, Brenner C, Campanella M, Candi E, Carmona-Gutierrez D, Cecconi F, Chan FK, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Cohen GM, Conrad M, Cubillos-Ruiz JR, Czabotar PE, D'Angiolella V, Dawson TM, Dawson VL, De Laurenzi V, De Maria R, Debatin KM, DeBerardinis RJ, Deshmukh M, Di Daniele N, Di Virgilio F, Dixit VM, Dixon SJ, Duckett CS, Dynlacht BD, El-Deiry WS, Elrod JW, Fimia GM, Fulda S, García-Sáez AJ, Garg AD, Garrido C, Gavathiotis E, Golstein P, Gottlieb E, Green DR, Greene LA, Gronemeyer H, Gross A, Hajnoczky G, Hardwick JM, Harris IS, Hengartner MO, Hetz C, Ichijo H, Jäättelä M, Joseph B, Jost PJ, Juin PP, Kaiser WJ, Karin M, Kaufmann T, Kepp O, Kimchi A, Kitsis RN, Klionsky DJ, Knight RA, Kumar S, Lee SW, Lemasters JJ, Levine B, Linkermann A, Lipton SA, Lockshin RA, López-Otín C, Lowe SW, Luedde T, Lugli E, MacFarlane M, Madeo F, Malewicz M, Malorni W, Manic G, Marine JC, Marti… See abstract for full author list ➔ Galluzzi L, et al. Cell Death Differ. 2018 Mar;25(3):486-541. doi: 10.1038/s41418-017-0012-4. Epub 2018 Jan 23. Cell Death Differ. 2018. PMID: 29362479 Free PMC article. Review.
  • Targeting Programmed Cell Death Using Small-Molecule Compounds to Improve Potential Cancer Therapy.
    Ke B, Tian M, Li J, Liu B, He G. Ke B, et al. Med Res Rev. 2016 Nov;36(6):983-1035. doi: 10.1002/med.21398. Epub 2016 Jun 30. Med Res Rev. 2016. PMID: 27357603 Review.
  • Mitotic catastrophe occurs in the absence of apoptosis in p53-null cells with a defective G1 checkpoint.
    Fragkos M, Beard P. Fragkos M, et al. PLoS One. 2011;6(8):e22946. doi: 10.1371/journal.pone.0022946. Epub 2011 Aug 10. PLoS One. 2011. PMID: 21853057 Free PMC article.
  • Necroptosis as a Novel Facet of Mitotic Catastrophe.
    Egorshina AY, Zamaraev AV, Kaminskyy VO, Radygina TV, Zhivotovsky B, Kopeina GS. Egorshina AY, et al. Int J Mol Sci. 2022 Mar 29;23(7):3733. doi: 10.3390/ijms23073733. Int J Mol Sci. 2022. PMID: 35409093 Free PMC article.

Cited by

References

    1. Lockshin RA, Williams CM. Programmed cell death – II. Endocrine potentiation of the breakdown of the intersegmental muscles of silkmoths. J Insect Physiol. 1964;10:643–649.
    1. Kerr JF. A histochemical study of hypertrophy and ischaemic injury of rat liver with special reference to changes in lysosomes. J Pathol Bacteriol. 1965;90:419–435. - PubMed
    1. Lockshin RA, Williams CM. Programmed cell death – I. Cytology of degeneration in the intersegmental muscles of the pernyi silkmoth. J Insect Physiol. 1965;11:123–133. - PubMed
    1. Schweichel JU, Merker HJ. The morphology of various types of cell death in prenatal tissues. Teratology. 1973;7:253–266. - PubMed
    1. Galluzzi L, Maiuri MC, Vitale I, Zischka H, Castedo M, Zitvogel L, et al. Cell death modalities: classification and pathophysiological implications. Cell Death Differ. 2007;14:1237–1243. - PubMed

Publication types